← Open Payments lookup

EDINA BOROS: Open Payments

NPI 1831602325 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,465 in 75 payments from 13 companies in 2025. Trend: 2023 $1,678 · 2024 $3,916 · 2025 $3,465

Food & beverage: $3,465
CompanyPaymentsAmount
ABBVIE INC.17$774
Neurocrine BioSciences, Inc.7$598
Alkermes, Inc.10$450
Otsuka America Pharmaceutical, Inc.7$375
Vanda Pharmaceuticals Inc.4$309
E.R. Squibb & Sons, L.L.C.13$252
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$236
Axsome Therapeutics, Inc.4$187
Teva Pharmaceuticals USA, Inc.1$124
Indivior Inc.3$71

Products named: VRAYLAR, INGREZZA, ARISTADA, FANAPT, REXULTI, CAPLYTA, COBENFY, Auvelity.

Industry payments across NV — which companies pay providers there.